The WACC of Sorrento Therapeutics Inc (SRNE) is 7.3%.
| Range | Selected | |
| Cost of equity | 91.90% - 120.60% | 106.25% |
| Tax rate | 0.60% - 1.60% | 1.10% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 5.6% - 9.0% | 7.3% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 19.14 | 20.66 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 91.90% | 120.60% |
| Tax rate | 0.60% | 1.60% |
| Debt/Equity ratio | 53.51 | 53.51 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 5.6% | 9.0% |
| Selected WACC | 7.3% | |